Anavex Life Sciences Corp (AVXL)

[Gator328]

They ought to open up the trials and allow more people to enroll.

The goal should be looking beyond approval. More data for a longer duration means less resistance from insurance companies. None of them are going to be excited about the prospect of reimbursing an expensive blockbuster drug that millions of people will begin taking all at once.

If we’re really concerned about the masses who are suffering though, it seems logical that Anavex should waive its patent rights and allow generics to hit the market ASAP particularly in developing nations, similar to what they’re trying to do with Covid-19 drugs. That would end the most suffering in the shortest period of time, no?